Trials / Terminated
TerminatedNCT01522170
aHUS Observational Long Term Follow-Up
An Observational, Multi-Center, Multi-National, Long Term Follow-Up Study of Atypical Hemolytic Uremic Syndrome (aHUS) Patients Treated With Eculizumab in a Prior Clinical Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 94 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
There is growing but limited information on the long term clinical status of aHUS patients who have previously received or are continuing to receive treatment with eculizumab. This study is designed to collect clinical data that will provide insight into the long-term outcomes of patients with aHUS.
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2012-01-31
- Last updated
- 2017-02-24
Locations
56 sites across 12 countries: United States, Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01522170. Inclusion in this directory is not an endorsement.